Nearly 300,000 women in England will be offered a preventative pill to help them avoid breast cancer. The drug, anastrozole, has been available for years as a breast cancer treatment, and had ...
Mauras et al. conducted a double-blind, randomized, placebo-controlled trial to determine whether estrogen suppression with the selective aromatase inhibitor anastrozole, administered to growth ...
Aromatase inhibitors are superior to tamoxifen as adjuvant therapy for postmenopausal women with early hormone-dependent breast cancer; however, whereas tamoxifen therapy reduces bone loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results